A detailed history of Marshall Wace, LLP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 467,123 shares of TXG stock, worth $7.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
467,123
Previous 35,401 1219.52%
Holding current value
$7.39 Million
Previous $688,000 1432.99%
% of portfolio
0.01%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.71 - $23.49 $6.78 Million - $10.1 Million
431,722 Added 1219.52%
467,123 $10.5 Million
Q2 2024

Aug 14, 2024

BUY
$19.45 - $37.37 $688,549 - $1.32 Million
35,401 New
35,401 $688,000
Q4 2023

Feb 14, 2024

BUY
$34.32 - $57.55 $257,949 - $432,545
7,516 New
7,516 $420,000
Q2 2023

Aug 14, 2023

BUY
$50.96 - $58.72 $10.1 Million - $11.6 Million
197,321 New
197,321 $11 Million
Q4 2022

Feb 14, 2023

BUY
$24.4 - $41.3 $470,139 - $795,768
19,268 New
19,268 $702,000
Q1 2022

May 16, 2022

SELL
$55.7 - $145.79 $540,512 - $1.41 Million
-9,704 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$135.05 - $182.59 $38.8 Million - $52.5 Million
-287,639 Reduced 96.74%
9,704 $1.45 Million
Q3 2021

Nov 15, 2021

BUY
$145.58 - $192.14 $43.3 Million - $57.1 Million
297,343 New
297,343 $43.3 Million
Q1 2021

May 17, 2021

SELL
$140.25 - $196.86 $36.1 Million - $50.6 Million
-257,149 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$126.47 - $163.7 $20.9 Million - $27.1 Million
165,325 Added 180.05%
257,149 $36.4 Million
Q3 2020

Nov 16, 2020

BUY
$87.44 - $125.0 $6.38 Million - $9.12 Million
72,924 Added 385.84%
91,824 $11.4 Million
Q2 2020

Aug 13, 2020

SELL
$58.39 - $89.31 $2.33 Million - $3.56 Million
-39,859 Reduced 67.83%
18,900 $1.69 Million
Q1 2020

May 15, 2020

BUY
$51.57 - $106.62 $3.03 Million - $6.26 Million
58,759 New
58,759 $3.66 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.